HPV Vaccine Integrated Service Implementation Research in Cameroon

Launched by POPULATION SERVICES INTERNATIONAL · Nov 8, 2024

Keywords

ClinConnect Summary

This clinical trial, called the HPV Vaccine Integrated Service Implementation Research in Cameroon, is focused on finding out if certain community-based programs can help more young boys and girls aged 9 to 13 get the HPV vaccine. The HPV vaccine is important because it can help prevent cancers caused by the human papillomavirus. The researchers are looking to see if these programs can make it easier for kids in the North and Far North Regions of Cameroon to access the vaccine and if the community will accept and support these efforts.

To do this, the study will compare vaccination rates in areas where these new programs are introduced with areas where they are not. The first phase of the study will involve interviews with key people like health officials, community leaders, and healthcare providers to gather information on how to best implement these vaccination programs. Only individuals identified as key informants will be included in this phase, and they will need to give their consent to participate. The study aims to learn more about how to improve HPV vaccination services for adolescents in Cameroon.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Key informant identified by study and implementation teams (purposive sampling by key informant type)
• Exclusion Criteria:
• • Does not provide written informed consent